Synphilin-1 Polyclonal Antibody

SNCAIP encodes Synphilin-1 containing several protein-protein interaction domains, including ankyrin-like repeats, a coiled-coil domain, and an ATP/GTP-binding motif. The synphilin-1 interacts with alpha-synuclein in neuronal tissue and may play a role in the formation of cytoplasmic inclusions and neurodegeneration. A mutation in this gene has been associated with Parkinson's disease. Alternative splicing results in multiple transcript variants.

The Synphilin-1 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Synphilin-1 protein expression in various biological samples. This antibody has been meticulously developed using advanced techniques to ensure exceptional sensitivity and specificity.

Synphilin-1 is a protein that has been implicated in the pathogenesis of neurodegenerative disorders, particularly Parkinson's disease. It plays a crucial role in protein degradation pathways and has been found to interact with key proteins involved in Parkinson's disease, such as alpha-synuclein and parkin.

The Synphilin-1 Polyclonal Antibody exhibits outstanding performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been extensively validated to provide accurate and reproducible results, making it an indispensable tool for researchers studying neurodegenerative diseases.

This antibody is produced using high-quality materials and undergoes rigorous quality control measures to ensure batch-to-batch consistency and reliability. It is supplied as a liquid formulation, ready for immediate use, and is compatible with a wide range of experimental conditions.

With its exceptional specificity and sensitivity, the Synphilin-1 Polyclonal Antibody is an invaluable asset for researchers seeking to unravel the intricate mechanisms underlying neurodegenerative disorders, particularly Parkinson's disease.